scholarly article | Q13442814 |
P50 | author | Junjie Li | Q52681468 |
P2093 | author name string | Timothy L Ratliff | |
Ji-Xin Cheng | |||
Liang Cheng | |||
Bing Song | |||
Xiaoqi Liu | |||
Timothy A Masterson | |||
Hyeon Jeong Lee | |||
Shuhua Yue | |||
Tian Shao | |||
Seung-Young Lee | |||
P2860 | cites work | SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth | Q24309283 |
The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations | Q24646816 | ||
Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes | Q24683425 | ||
A simple method for the isolation and purification of total lipides from animal tissues | Q25939009 | ||
Cancer statistics, 2012 | Q27860574 | ||
The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor | Q28238069 | ||
SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene | Q28264180 | ||
Dynamics of lipid droplets induced by the hepatitis C virus core protein | Q39672665 | ||
Acyl-coenzyme A: cholesterol acyltransferase inhibitor Avasimibe affect survival and proliferation of glioma tumor cell lines | Q39712980 | ||
Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon cancer cells | Q40002578 | ||
Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. | Q40833413 | ||
Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. | Q41120850 | ||
Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. | Q41164689 | ||
The LDL receptor pathway delivers arachidonic acid for eicosanoid formation in cells stimulated by platelet-derived growth factor | Q41731121 | ||
Lipid droplets finally get a little R-E-S-P-E-C-T. | Q41828556 | ||
Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells | Q42457991 | ||
High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation | Q42461741 | ||
Lipofuscin granules in normal, benign and malignant human prostatic tissue | Q43465734 | ||
Fatty acid regulates gene expression and growth of human prostate cancer PC-3 cells | Q43589116 | ||
Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model | Q43900265 | ||
Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence | Q44802900 | ||
Mechanisms of androgen-refractory prostate cancer | Q45094999 | ||
Arachidonic acid activates phosphatidylinositol 3-kinase signaling and induces gene expression in prostate cancer | Q46923183 | ||
High throughput quantification of cholesterol and cholesteryl ester by electrospray ionization tandem mass spectrometry (ESI-MS/MS). | Q46928125 | ||
Androgen-Independent Prostate Cancer Is a Heterogeneous Group of Diseases | Q57693579 | ||
Cholesterol esters as growth regulators of lymphocytic leukaemia cells | Q60540979 | ||
Lipid-rich carcinoma of the breast. A clinicopathologic analysis of 13 examples | Q69740657 | ||
Enhancement of the LC/MS analysis of fatty acids through derivatization and stable isotope coding | Q80306826 | ||
The phosphatidylinositol 3-Kinase AKT pathway in human cancer | Q29547860 | ||
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis | Q29615683 | ||
Abiraterone and increased survival in metastatic prostate cancer | Q29617512 | ||
Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase | Q30470670 | ||
Quantitative label-free imaging of lipid composition and packing of individual cellular lipid droplets using multiplex CARS microscopy | Q30484406 | ||
Highly Sensitive Vibrational Imaging by Femtosecond Pulse Stimulated Raman Loss | Q30501662 | ||
Remodeling of lipid droplets during lipolysis and growth in adipocytes | Q30512876 | ||
Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2 | Q30523968 | ||
1H NMR visible lipids in the life and death of cells | Q30604603 | ||
Nonperturbative chemical imaging of organelle transport in living cells with coherent anti-stokes Raman scattering microscopy | Q33240794 | ||
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer | Q33421665 | ||
High-speed vibrational imaging and spectral analysis of lipid bodies by compound Raman microscopy | Q33440785 | ||
Dietary fat and prostate cancer: current status | Q33539814 | ||
Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol | Q33769607 | ||
Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis | Q33914549 | ||
Eicosanoids and cancer | Q33966203 | ||
The biogenesis and functions of lipid bodies in animals, plants and microorganisms | Q34084932 | ||
Shedding new light on lipid biology with coherent anti-Stokes Raman scattering microscopy | Q34187941 | ||
Pharmacology of the ACAT inhibitor avasimibe (CI-1011). | Q35069596 | ||
Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth | Q35168294 | ||
Polo-like kinase 1 facilitates loss of Pten tumor suppressor-induced prostate cancer formation | Q35371690 | ||
Targeting the PI3K-Akt pathway in human cancer: rationale and promise | Q35571372 | ||
Label-free imaging of lipid-droplet intracellular motion in early Drosophila embryos using femtosecond-stimulated Raman loss microscopy. | Q35866792 | ||
Monitoring of lipid storage in Caenorhabditis elegans using coherent anti-Stokes Raman scattering (CARS) microscopy | Q35990206 | ||
Cholesterol sensing, trafficking, and esterification. | Q36497100 | ||
The role of cholesterol in prostate cancer | Q36508469 | ||
Statin drugs and risk of advanced prostate cancer | Q36688183 | ||
Cellular cholesterol trafficking and compartmentalization | Q37064008 | ||
PTEN and the PI3-kinase pathway in cancer | Q37259680 | ||
Targeting the PI3K/AKT pathway for the treatment of prostate cancer | Q37564760 | ||
Lipid metabolism in cancer | Q38012542 | ||
How cancer metabolism is tuned for proliferation and vulnerable to disruption | Q38059777 | ||
Nonlinear vibrational microscopy applied to lipid biology. | Q38139725 | ||
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. | Q38467346 | ||
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway | Q38926285 | ||
Comparative effects of high and low-dose simvastatin on prostate epithelial cells: the role of LDL. | Q39450194 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
P304 | page(s) | 393-406 | |
P577 | publication date | 2014-03-01 | |
P1433 | published in | Cell Metabolism | Q1254684 |
P1476 | title | Cholesteryl ester accumulation induced by PTEN loss and PI3K/AKT activation underlies human prostate cancer aggressiveness | |
P478 | volume | 19 |
Q37032010 | A Drosophila Genome-Wide Screen Identifies Regulators of Steroid Hormone Production and Developmental Timing |
Q64226349 | A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition |
Q95267229 | ACAT2 Promotes Cell Proliferation and Associates with Malignant Progression in Colorectal Cancer |
Q49333945 | ATP-binding cassette transporter A1: A promising therapy target for prostate cancer. |
Q26744233 | Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis |
Q38774151 | Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer |
Q38905777 | Activated α2-macroglobulin binding to human prostate cancer cells triggers insulin-like responses |
Q38248879 | Acyl-CoA:cholesterol acyltransferases (ACATs/SOATs): Enzymes with multiple sterols as substrates and as activators. |
Q41528938 | An Overview of Lipid Droplets in Cancer and Cancer Stem Cells |
Q26748844 | Androgen control of lipid metabolism in prostate cancer: novel insights and future applications |
Q30617345 | Assessing cholesterol storage in live cells and C. elegans by stimulated Raman scattering imaging of phenyl-Diyne cholesterol |
Q93163237 | Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancer |
Q92914776 | Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression-An in vitro study |
Q37045608 | Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories |
Q34516773 | Attacking the supply wagons to starve cancer cells to death |
Q51010232 | Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment. |
Q93023928 | Biological imaging of chemical bonds by stimulated Raman scattering microscopy |
Q47635545 | Bioorthogonal chemical imaging of metabolic changes during epithelial-mesenchymal transition of cancer cells by stimulated Raman scattering microscopy |
Q26748979 | Bond-selective photoacoustic imaging by converting molecular vibration into acoustic waves |
Q51159201 | Bottom up design of nanoparticles for anti-cancer diapeutics: "put the drug in the cancer's food". |
Q52695559 | Bryonolic Acid Blocks Cancer Cell Clonogenicity and Invasiveness through the Inhibition of Fatty Acid: Cholesteryl Ester Formation. |
Q46085514 | CDCP1 drives triple-negative breast cancer metastasis through reduction of lipid-droplet abundance and stimulation of fatty acid oxidation |
Q90380782 | Calcitonin receptor is required for T-antigen-induced prostate carcinogenesis |
Q38248260 | Cancer chemoprevention with nuts |
Q92928336 | Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis |
Q91724744 | Cell Cycle Progression Regulates Biogenesis and Cellular Localization of Lipid Droplets |
Q39180626 | Cellular Cholesterol Homeostasis in Alzheimer's Disease |
Q47951459 | Ceramide Is Metabolized to Acylceramide and Stored in Lipid Droplets |
Q51739580 | Cholesterol Esterification Inhibition Suppresses Prostate Cancer Metastasis by Impairing the Wnt/β-catenin Pathway. |
Q64114610 | Cholesterol Sulfotransferase SULT2B1b Modulates Sensitivity to Death Receptor Ligand TNFα in Castration-Resistant Prostate Cancer |
Q36106400 | Cholesterol and prostate cancer risk: a long-term prospective cohort study |
Q24658633 | Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer |
Q52681396 | Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation. |
Q38673775 | Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia |
Q97643510 | Cholesterol metabolism in cancer: mechanisms and therapeutic opportunities |
Q54960557 | Cholesterol synthesis pathway genes in prostate cancer are transcriptionally downregulated when tissue confounding is minimized. |
Q40167193 | Cholesterol uptake and regulation in high-grade and lethal prostate cancers. |
Q35134601 | Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma |
Q36151318 | Clinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma |
Q35826508 | Coherent Raman Scattering Microscopy in Biology and Medicine |
Q38909985 | Colocalization of fluorescence and Raman microscopic images for the identification of subcellular compartments: a validation study |
Q64109342 | Cylindrical illumination with angular coupling for whole-prostate photoacoustic tomography |
Q38862186 | Deciphering single cell metabolism by coherent Raman scattering microscopy |
Q52761605 | Deconstructing the Metabolic Networks of Oncogenic Signaling Using Targeted Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS). |
Q47107657 | Dendrogenin A drives LXR to trigger lethal autophagy in cancers. |
Q50324524 | Depletion of membrane cholesterol compromised caspase-8 imparts in autophagy induction and inhibition of cell migration in cancer cells. |
Q50627860 | Determination of the sputtering yield of cholesterol using Arn(+) and C60(+(+)) cluster ions. |
Q35819797 | Developments in spontaneous and coherent Raman scattering microscopic imaging for biomedical applications. |
Q48156526 | Differential effects of sPLA2-GV and GX on cellular proliferation and lipid accumulation in HT29 colon cancer cells. |
Q30596444 | Direct visualization of de novo lipogenesis in single living cells |
Q36430122 | Distinct cholesterogenic and lipidogenic gene expression patterns in ovarian cancer - a new pool of biomarkers |
Q57629429 | Dropping in on lipid droplets: insights into cellular stress and cancer |
Q64271866 | Effect of PTEN loss on metabolic reprogramming in prostate cancer cells |
Q51168142 | Epigenetic Downregulation of PTEN in Gallbladder Cancer. |
Q43450920 | Establishment and phenotyping of disease model cells created by cell-resealing technique |
Q90503839 | Even Cancer Cells Watch Their Cholesterol! |
Q92669265 | Expression and significance of PTEN and Claudin-3 in prostate cancer |
Q64935776 | Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration. |
Q61798994 | Ezetimibe suppresses development of liver tumors by inhibiting angiogenesis in mice fed a high-fat diet |
Q97523290 | FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer |
Q92637519 | FDPS cooperates with PTEN loss to promote prostate cancer progression through modulation of small GTPases/AKT axis |
Q37721829 | FUSION-Guided Hypothesis Development Leads to the Identification of N⁶,N⁶-Dimethyladenosine, a Marine-Derived AKT Pathway Inhibitor. |
Q34070268 | Fast vibrational imaging of single cells and tissues by stimulated Raman scattering microscopy. |
Q104101361 | Fat and Furious: Lipid Metabolism in Antitumoral Therapy Response and Resistance |
Q55468609 | Fatty Acids and Calcium Regulation in Prostate Cancer. |
Q90720649 | Fibrin-Hyaluronic Acid Hydrogel (RegenoGel) with Fibroblast Growth Factor-18 for In Vitro 3D Culture of Human and Bovine Nucleus Pulposus Cells |
Q26778586 | Genomic and Histopathological Tissue Biomarkers That Predict Radiotherapy Response in Localised Prostate Cancer |
Q38892263 | HIF2α-Dependent Lipid Storage Promotes Endoplasmic Reticulum Homeostasis in Clear-Cell Renal Cell Carcinoma. |
Q91900522 | HILPDA Regulates Lipid Metabolism, Lipid Droplet Abundance, and Response to Microenvironmental Stress in Solid Tumors |
Q47655012 | HMG-CoA reductase inhibition delays DNA repair and promotes senescence after tumor irradiation |
Q74436073 | High cholesterol in prostate tumours |
Q35113473 | High-calorie diet exacerbates prostate neoplasia in mice with haploinsufficiency of Pten tumor suppressor gene |
Q90411797 | Highlight article: The role of cholesterol and cholesterol-driven membrane raft domains in prostate cancer |
Q39459629 | Imaging chemistry inside living cells by stimulated Raman scattering microscopy |
Q89599348 | Impairment of Membrane Lipid Homeostasis by Bichalcone Analog TSWU-BR4 Attenuates Function of GRP78 in Regulation of the Oxidative Balance and Invasion of Cancer Cells |
Q36053413 | In Situ and In Vivo Molecular Analysis by Coherent Raman Scattering Microscopy |
Q88084647 | In vitro exploration of ACAT contributions to lipid droplet formation during adipogenesis |
Q44664369 | Increased transcriptional and metabolic capacity for lipid metabolism in the peripheral zone of the prostate may underpin its increased susceptibility to cancer. |
Q55318851 | Insulin promotes progression of colon cancer by upregulation of ACAT1. |
Q36569962 | Integration of lipidomics and transcriptomics unravels aberrant lipid metabolism and defines cholesteryl oleate as potential biomarker of prostate cancer |
Q36738856 | Integration of tissue metabolomics, transcriptomics and immunohistochemistry reveals ERG- and gleason score-specific metabolomic alterations in prostate cancer |
Q52724160 | Interlink between cholesterol & cell cycle in prostate carcinoma. |
Q38626078 | Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation. |
Q27318691 | Label-free DNA imaging in vivo with stimulated Raman scattering microscopy. |
Q36188853 | Leptin activation of mTOR pathway in intestinal epithelial cell triggers lipid droplet formation, cytokine production and increased cell proliferation. |
Q53511661 | Leptin promotes the migration and invasion of breast cancer cells by upregulating ACAT2. |
Q53644558 | Letter to the editor: An intriguing relationship between lipid droplets, cholesterol-binding protein CD133 and Wnt/β-catenin signaling pathway in carcinogenesis. |
Q58692616 | Lipid Droplets in Cancer: Guardians of Fat in a Stressful World |
Q28078259 | Lipid Droplets: A Key Cellular Organelle Associated with Cancer Cell Survival under Normoxia and Hypoxia |
Q47754576 | Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells. |
Q91310925 | Lipid Metabolism at the Nexus of Diet and Tumor Microenvironment |
Q46558055 | Lipid droplets, potential biomarker and metabolic target in glioblastoma |
Q89582471 | Lipid droplets: platforms with multiple functions in cancer hallmarks |
Q90749099 | Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer |
Q26774859 | Lipid metabolic reprogramming in cancer cells |
Q55405747 | Lipid metabolism and carcinogenesis, cancer development. |
Q27025766 | Lipid metabolism in prostate cancer |
Q88761261 | Lipid metabolism reprogramming and its potential targets in cancer |
Q64913993 | Lipid profiles of prostate cancer cells. |
Q36323141 | Lipid quantification by Raman microspectroscopy as a potential biomarker in prostate cancer |
Q58757941 | Lipidomic profiling of extracellular vesicles derived from prostate and prostate cancer cell lines |
Q42139966 | Lipogenic metabolism: a viable target for prostate cancer treatment? |
Q92051968 | Lipoprotein Drug Delivery Vehicles for Cancer: Rationale and Reason |
Q92647197 | Lipoproteins modulate growth and P-glycoprotein expression in drug-resistant HER2-overexpressed breast cancer cells |
Q36545158 | Liver X receptor reduces proliferation of human oral cancer cells by promoting cholesterol efflux via up-regulation of ABCA1 expression |
Q41621402 | Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer. |
Q52822414 | LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway. |
Q93238104 | LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer |
Q42376034 | Loss of ABHD5 promotes the aggressiveness of prostate cancer cells |
Q92392344 | Loss of cell polarity regulated by PTEN/Cdc42 enrolled in the process of Hepatopulmonary Syndrome |
Q38918249 | Lovastatin enhances adenovirus-mediated TRAIL induced apoptosis by depleting cholesterol of lipid rafts and affecting CAR and death receptor expression of prostate cancer cells |
Q37584298 | Low Density Lipoproteins Amplify Cytokine-signaling in Chronic Lymphocytic Leukemia Cells |
Q49865078 | Lysophosphatidylcholine acyltransferase 2-mediated lipid droplet production supports colorectal cancer chemoresistance. |
Q88144021 | Lysosomal acid lipase promotes cholesterol ester metabolism and drives clear cell renal cell carcinoma progression |
Q92059973 | Mechanisms and regulation of cholesterol homeostasis |
Q49871101 | Metabolic Footprints and Molecular Subtypes in Breast Cancer. |
Q49921472 | Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities. |
Q52731934 | Metabolic features of cancer stem cells: the emerging role of lipid metabolism. |
Q90672641 | Metabolic reprogramming in tumors: Contributions of the tumor microenvironment |
Q35935362 | Metabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS study |
Q64061518 | Metabolism-Based Therapeutic Strategies Targeting Cancer Stem Cells |
Q60916952 | Methylseleninic Acid Induces Lipid Peroxidation and Radiation Sensitivity in Head and Neck Cancer Cells |
Q38703092 | MiR-106b and miR-93 regulate cell progression by suppression of PTEN via PI3K/Akt pathway in breast cancer. |
Q39193874 | Mice lacking lipid droplet-associated hydrolase, a gene linked to human prostate cancer, have normal cholesterol ester metabolism |
Q64260733 | Micro-Surface and -Interfacial Tensions Measured Using the Micropipette Technique: Applications in Ultrasound-Microbubbles, Oil-Recovery, Lung-Surfactants, Nanoprecipitation, and Microfluidics |
Q38815056 | MicroRNA: a connecting road between apoptosis and cholesterol metabolism |
Q30657412 | Microsecond Scale Vibrational Spectroscopic Imaging by Multiplex Stimulated Raman Scattering Microscopy. |
Q92580054 | Mitochondria Bound to Lipid Droplets: Where Mitochondrial Dynamics Regulate Lipid Storage and Utilization |
Q50897128 | Modulating cancer cell survival by targeting intracellular cholesterol transport. |
Q34365632 | Molecular pathways and targets in prostate cancer |
Q42372781 | Multicellular tumor spheroids of human uveal melanoma induce genes associated with anoikis resistance, lipogenesis, and SSXs |
Q90369325 | Multiplex Stimulated Raman Scattering Imaging Cytometry Reveals Lipid-Rich Protrusions in Cancer Cells under Stress Condition |
Q100490888 | Multiplex coherent anti-Stokes Raman scattering microspectroscopy detection of lipid droplets in cancer cells expressing TrkB |
Q49988596 | Natural Forms of Vitamin E as Effective Agents for Cancer Prevention and Therapy. |
Q35607792 | Neutral lipid alterations in human herpesvirus 8-infected HUVEC cells and their possible involvement in neo-angiogenesis |
Q57107495 | New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors |
Q39456875 | Nutrient Exploitation within the Tumor-Stroma Metabolic Crosstalk |
Q28084566 | Nutrition, dietary interventions and prostate cancer: the latest evidence |
Q42342119 | Observation-driven inquiry: Raman spectroscopic imaging illuminates cancer lipid metabolism |
Q52329039 | Omega-3 fatty acids, membrane remodeling and cancer prevention. |
Q41143825 | On-line visualization of multicolor chemical images with stimulated Raman scattering spectral microscopy |
Q37497314 | Oncogenic mutations and dysregulated pathways in obesity-associated hepatocellular carcinoma. |
Q38846889 | Oral simvastatin administration delays castration-resistant progression and reduces intratumoral steroidogenesis of LNCaP prostate cancer xenografts |
Q52639519 | PTEN deficiency and AMPK activation promote nutrient scavenging and anabolism in prostate cancer cells. |
Q90441646 | PTEN in propofol-induced insulin resistance in mouse primary hepatocytes |
Q58801432 | Photoacoustic tomography of intact human prostates and vascular texture analysis identify prostate cancer biopsy targets |
Q38953636 | Plk1 inhibition enhances the efficacy of androgen signaling blockade in castration-resistant prostate cancer |
Q41591994 | Positive regulation of prostate cancer cell growth by lipid droplet forming and processing enzymes DGAT1 and ABHD5. |
Q37591701 | Pro-inflammation NF-κB signaling triggers a positive feedback via enhancing cholesterol accumulation in liver cancer cells |
Q42748239 | Prognostic value of ERG, PTEN, CRISP3 and SPINK1 in predicting biochemical recurrence in prostate cancer |
Q92410918 | Prostate Cancer Energetics and Biosynthesis |
Q91870122 | Proteomic profiling in liver cancer: another new page |
Q91987072 | Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma |
Q35664021 | Pten Regulates Epithelial Cytodifferentiation during Prostate Development |
Q57784594 | Quantitative imaging of lipid droplets in single cells |
Q89458905 | RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cellss |
Q90662697 | RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype |
Q33762061 | Raman and coherent anti-Stokes Raman scattering microscopy studies of changes in lipid content and composition in hormone-treated breast and prostate cancer cells |
Q99710788 | Raman-guided subcellular pharmaco-metabolomics for metastatic melanoma cells |
Q48316610 | Rational Targeting of Cellular Cholesterol in Diffuse Large B-Cell Lymphoma (DLBCL) Enabled by Functional Lipoprotein Nanoparticles: A Therapeutic Strategy Dependent on Cell of Origin |
Q92932387 | Regulation of T cell antitumor immune response by tumor induced metabolic stress |
Q35768176 | Role of diet in prostate cancer: the epigenetic link |
Q89230444 | Runx1 Role in Epithelial and Cancer Cell Proliferation Implicates Lipid Metabolism and Scd1 and Soat1 Activity |
Q64998467 | SREBPs in Lipid Metabolism, Insulin Signaling, and Beyond. |
Q92545423 | SRY‑related HMG box‑2 role in anaplastic thyroid cancer aggressiveness is related to the fibronectin 1 and PI3K/AKT pathway |
Q88796162 | Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer |
Q89846977 | Silencing of PTEN inhibits the oxidative stress damage and hippocampal cell apoptosis induced by Sevoflurane through activating MEK1/ERK signaling pathway in infant rats |
Q38949811 | Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1. |
Q89900464 | Spatial modeling of prostate cancer metabolic gene expression reveals extensive heterogeneity and selective vulnerabilities |
Q57072613 | Sterol Metabolism and Transport in Atherosclerosis and Cancer |
Q92815757 | Sterol O-Acyl Transferase 1 as a Prognostic Marker of Adrenocortical Carcinoma |
Q95320675 | Structural basis for catalysis and substrate specificity of human ACAT1 |
Q95326418 | Structural insights into the inhibition mechanism of human sterol O-acyltransferase 1 by a competitive inhibitor |
Q55482080 | Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy. |
Q52724791 | TIPE‑2 suppresses growth and aggressiveness of hepatocellular carcinoma cells through downregulation of the phosphoinositide 3‑kinase/AKT signaling pathway. |
Q92178473 | Targeting Long Chain Acyl-CoA Synthetases for Cancer Therapy |
Q91669842 | Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer |
Q37395800 | Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways |
Q92573701 | Targeting extracellular nutrient dependencies of cancer cells |
Q28070244 | Targeting the SR-B1 Receptor as a Gateway for Cancer Therapy and Imaging |
Q39277021 | The Association of Dyslipidemia With Chronic Lymphocytic Leukemia: A Population-Based Study |
Q40649810 | The HDL receptor SR-BI is associated with human prostate cancer progression and plays a possible role in establishing androgen independence. |
Q59529106 | The Involvement of PPARs in the Peculiar Energetic Metabolism of Tumor Cells |
Q38838555 | The Role of Cholesterol in Cancer |
Q38936241 | The Role of Glucose and Lipid Metabolism in Growth and Survival of Cancer Cells |
Q38800777 | The current evidence on statin use and prostate cancer prevention: are we there yet? |
Q90070054 | The dysfunctional lipids in prostate cancer |
Q38821546 | The emerging role of obesity, diet and lipid metabolism in prostate cancer |
Q90620365 | The expanded role of fatty acid metabolism in cancer: new aspects and targets |
Q38937455 | The interplay between cell signalling and the mevalonate pathway in cancer |
Q29694341 | The multifaceted roles of fatty acid synthesis in cancer |
Q33714092 | The role of adipose tissue and obesity in causing treatment resistance of acute lymphoblastic leukemia |
Q88091776 | Thyroid transcription factor 1 enhances cellular statin sensitivity via perturbing cholesterol metabolism |
Q58764584 | Triglycerides Promote Lipid Homeostasis during Hypoxic Stress by Balancing Fatty Acid Saturation |
Q38431287 | Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study |
Q46381784 | Uncovering Structural Diversity of Unsaturated Fatty Acyls in Cholesteryl Esters via Photochemical Reaction and Tandem Mass Spectrometry. |
Q49554294 | Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma. |
Q38650243 | Vibrational spectroscopic imaging of living systems: An emerging platform for biology and medicine |
Q97524330 | Withania somnifera root extract inhibits fatty acid synthesis in prostate cancer cells |
Search more.